I

InventisBio Co Ltd
SSE:688382

Watchlist Manager
InventisBio Co Ltd
SSE:688382
Watchlist
Price: 27.24 CNY 0.15% Market Closed
Market Cap: 15.8B CNY

Wall Street
Price Targets

Price Targets Summary
InventisBio Co Ltd

Wall Street analysts forecast InventisBio Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for InventisBio Co Ltd is 50.24 CNY with a low forecast of 49.74 CNY and a high forecast of 51.71 CNY.

Lowest
Price Target
49.74 CNY
83% Upside
Average
Price Target
50.24 CNY
84% Upside
Highest
Price Target
51.71 CNY
90% Upside
InventisBio Co Ltd Competitors:
Price Targets
4587
PeptiDream Inc
94% Upside
ENTA
Enanta Pharmaceuticals Inc
35% Upside
SPRY
ARS Pharmaceuticals Inc
147% Upside
251120
Bio-FD&C Co Ltd
23% Upside
688520
Sinocelltech Group Ltd
30% Upside
ALEC
Alector Inc
37% Upside
4BB
4Basebio PLC
182% Upside
ALKS
Alkermes Plc
58% Upside

Revenue
Forecast

Revenue Estimate
InventisBio Co Ltd

The compound annual growth rate of InventisBio Co Ltd's revenue for the next 3 years is 58%.

N/A
Past Growth
58%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
InventisBio Co Ltd

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
InventisBio Co Ltd

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is InventisBio Co Ltd's stock price target?
Price Target
50.24 CNY

According to Wall Street analysts, the average 1-year price target for InventisBio Co Ltd is 50.24 CNY with a low forecast of 49.74 CNY and a high forecast of 51.71 CNY.

What is InventisBio Co Ltd's Revenue forecast?
Projected CAGR
58%

The compound annual growth rate of InventisBio Co Ltd's revenue for the next 3 years is 58%.

Back to Top